The American Veterinary Medical Association’s recent “response” to the Pew Commission on Industrial Farm Animal Production’s final report on the state of industrial animal agriculture is disconcerting. It appears that leadership of the veterinary professional organization is attempting to misuse science to obfuscate and delay critically needed changes in the food animal production system rather than tackling very real public health and environmental threats head on.
For years a groundswell had been building from a widespread group of experts and advocates in the areas of public health, environment, social justice, and animal welfare sounding the alarms about the serious problems industrial food animal production poses. But until the Pew Commission on Industrial Farm Animal Production (PCIFAP) decided to take on the politically controversial issue, there had never been a comprehensive examination of industry’s practices by such a respected and diverse panel of experts. Following a grueling 2½ -year discovery process, and despite several overt attempts by industry to discredit it, the Commission concluded that the scientific evidence was too strong and the public health risk too great to ignore and offered a series of consensus recommendations on how to repair our unsafe food animal production system.
The tone and timing of the AVMA’s 38-page response to the PCIFAP final report, 15 months after it was released, is quite telling. The document’s executive summary starts out by suggesting that the PCIFAP’s technical reports (published separately) were “biased,” and that, “the Pew report contains significant flaws and major deviations from both science and reality.” Another telling facet is that the “response” contains very little scientific citation to backup its rebuttal. It’s not a coincidence that this response coincides with the recent revelation that the Obama Administration supports the idea of banning the use of key antibiotics as growth promoters in food animals, which happens to be one of the PCIFAP’s key recommendations. Not to mention, this year’s version of the Preservation of Antibiotics for Medical Treatment Act (PAMTA) appears to have a much better chance of passing than in any prior year.